- Issuer ticker
-
DMII
- Reported as of
-
26 Sep 2025
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
01 Oct 2025, 10:34:02 UTC
Filing notes and source
Key filing fact
G. Sridhar Prasad filed Form 4 for Drugs Made In America Acquisition II Corp. (DMII) on 01 Oct 2025.
Key facts
- This page summarizes G. Sridhar Prasad's Form 4 filing for Drugs Made In America Acquisition II Corp. (DMII).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Oct 2025, 10:34.
Change
- Previous filing in this sequence was filed on 24 Sep 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002038368
Primary reporting owner
Prasad Sridhar G.
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DMII
transaction
Ordinary shares
Other
- Transaction value
- Shares
- +100,000
- Change %
- Price
-
- Shares after
- 100,000
- Date
- 26 Sep 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote